ISSN: 2332-0877

Revista de terapia y enfermedades infecciosas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Clinical Significance of a Combination of Biochemical Indexes and Immunity Indexes for Hepatitis B Disease Prediction

Wenyan Zhang, Chang Liu, Shan Chen and Junzheng Yang*

Introduction: To explore the clinical significance of the detection of biochemical indexes and immune indexes in the prediction of hepatitis B (HBV) disease. Method: 150 patients with HBV disease who were treated in our hospital from 2018 to 2020 were selected and divided into acute HBV group (group A), chronic HBV group (group B) and Cirrhosis group (C group), every group included 50 cases and 50 healthy people were selected as the control group. Peripheral venous blood was collected from subjects from 4 groups, and immune indexes (plasma immunoglobulin G (IgG), plasma immunoglobulin A (IgA), plasma immunoglobulin M (IgM)) of HBV were measured by immune nephelometry, and biochemical indexes (alanine aminotransferase (ALT) and amino acid transaminase (AST)) of HBV were measured by fasting rate method. Results: Compared with the control group, the immune nephelometry results and fasting rate method showed that the expression of immune indexes (IgG, IgA and IgM) and the expression of biochemical indexes (ALT and AST)in group A, B and C patients were increased significantly (P<0.05). Conclusion: The detection of immune indexes and biochemical indexes has important clinical significance in prediction of HBV patients' condition, and detect a combination of biochemical indexes and immune indexes can be used to make a comprehensive judgment to provide a reliable laboratory basis for diagnosis of HBV patients' condition.